Russia’s Invasion of Ukraine: Get the latest insights from our experts about the conflict, the impact on the world economy, and what it might mean for the future.

All Insights

GLG's articles and eBooks are drawn from the insight of the best and brightest, our approximately 1 million Network Members, which include thought leaders across every major sector and geography. You'll also find research best practices from our internal teams as well as Spotlights on how we've helped companies like yours get the clarity to act with confidence.

Biogen’s Aduhelm: An Update on the Commercial Rollout
Article

Biogen’s Aduhelm: An Update on the Commercial Rollout

FDA’s Controversial Aduhelm Approval: What Happens Next?
Article

FDA’s Controversial Aduhelm Approval: What Happens Next?

Why the FDA Was Correct in Approving Biogen’s Aducanumab
Article

Why the FDA Was Correct in Approving Biogen’s Aducanumab

Subscribe to Insights 360

Enter your email below and receive our monthly newsletter, featuring insights from GLG’s network of approximately 1 million professionals with first-hand expertise in every industry.